PRCM
IART icon

Pine River Capital Management’s Integra LifeSciences IART Stock Holding History

Pine River Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-124,600
Closed -$3.71M – 698
2015
Q3 		$3.71M Buy
+124,600
New +$3.9M 0.05% 232

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Pine River Capital Management's IART Position: Q4 2015 in Review

Pine River Capital Management sold out of Integra LifeSciences (IART) in Q4 2015, closing a stake of 124,600 shares — an estimated $3.71M sold.

Pine River Capital Management first reported a position in IART in Q3 2015 and held it in 1 quarter. The position peaked at $3.71M in Q3 2015. 186 funds tracked by Wall St. Rank hold IART as of Q4 2015.

  • Pine River Capital Management reported no remaining Integra LifeSciences position as of Q4 2015 after selling out during the quarter.
  • Pine River Capital Management sold 124,600 Integra LifeSciences shares in Q4 2015, an estimated $3.71M.
  • Pine River Capital Management first reported a position in Integra LifeSciences in Q3 2015 and held it in 1 quarter.
  • Pine River Capital Management's Integra LifeSciences position peaked at $3.71M in Q3 2015.
  • 186 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2015.

Based on Pine River Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.